Virpax Pharmaceuticals Stock Alpha and Beta Analysis
| VRPX Stock | USD 0.59 0.03 4.84% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Virpax Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Virpax Pharmaceuticals over a specified time horizon. Remember, high Virpax Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Virpax Pharmaceuticals' market risk premium analysis include:
Beta 2.2 | Alpha (0.78) | Risk 7.12 | Sharpe Ratio (0.04) | Expected Return (0.25) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Virpax |
Virpax Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Virpax Pharmaceuticals market risk premium is the additional return an investor will receive from holding Virpax Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Virpax Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Virpax Pharmaceuticals' performance over market.| α | -0.78 | β | 2.20 |
Virpax Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Virpax Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Virpax Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Virpax Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Virpax Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Virpax Pharmaceuticals shares will generate the highest return on investment. By understating and applying Virpax Pharmaceuticals stock market price indicators, traders can identify Virpax Pharmaceuticals position entry and exit signals to maximize returns.
Virpax Pharmaceuticals Return and Market Media
The median price of Virpax Pharmaceuticals for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 0.7 with a coefficient of variation of 15.85. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 0.69, and mean deviation of 0.08. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Virpax Pharmaceuticals Overhauls Leadership and Auditor Amid Concerns - TipRanks | 09/25/2024 |
2 | Virpax Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com | 10/04/2024 |
3 | Acquisition by Jatinder Dhaliwal of 2500 shares of Virpax Pharmaceuticals at 0.578 subject to Rule 16b-3 | 10/25/2024 |
4 | Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer | 11/05/2024 |
5 | Virpax Pharmaceuticals, Inc. Announces Pricing of 5.0 Million Public Offering of Common Stock and Pre-Funded Warrants | 11/13/2024 |
6 | Virpax Pharmaceuticals Announces 5.0 Million Public Offering and Investor Relations AgreementBERWYN, PA November 15, 2024 - Virpax Pharmaceuticals, Inc. recentl... | 11/18/2024 |
7 | Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic No... | 11/21/2024 |
About Virpax Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Virpax or other stocks. Alpha measures the amount that position in Virpax Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Virpax Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Virpax Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Virpax Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Virpax Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Virpax Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Virpax Pharmaceuticals' management manipulating its earnings.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Virpax Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Virpax Stock Analysis
When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.